We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

15 hedge funds and large institutions have $525K invested in Clovis Oncology, Inc. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

85% less funds holding

Funds holding: 103 → 15 (-88)

98% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 90

99% less capital invested

Capital invested by funds: $42.9M → $525K (-$42.4M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
-88
Holders Change %
-85.44%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
90
Calls
$22K
Puts
–
Net Calls
+$22K
Net Calls Change
-$2.59M

Top Buyers

Rank Fund Capital Flow
1
STB
S&T Bank
Pennsylvania
+$13.2K
2
IA
IFP Advisors
Florida
+$33

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$12.1M
2
PAI
Palo Alto Investors
California
-$5.32M
3
BlackRock
BlackRock
New York
-$4.8M
4
QF
QVT Financial
New York
-$4.2M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
$479K +$33 +50 +0.5%
Macquarie Group
2
Macquarie Group
Australia
$13K – – –
CAS
3
Coppell Advisory Solutions
Texas
$12.7K +$174 +265 New
CASC
4
Coppell Advisory Solutions Corp
Texas
$12.7K +$174 +265 New
STB
5
S&T Bank
Pennsylvania
$3K +$13.2K +20,000 +50%
MCM
6
MAI Capital Management
Ohio
$1.05K – – –
WS
7
Wedbush Securities
California
$1K – – –
FFWM
8
Future Financial Wealth Management
Ohio
$712 – – –
NFSG
9
Newbridge Financial Services Group
Florida
$659 – – –
Qube Research & Technologies (QRT)
10
Qube Research & Technologies (QRT)
United Kingdom
$632 -$5.33K -8,098 -40%
QC
11
Quent Capital
New York
$12 – – –
Vanguard Group
12
Vanguard Group
Pennsylvania
– -$12.1M -10,206,509 Closed
PAI
13
Palo Alto Investors
California
– -$5.32M -4,473,967 Closed
BlackRock
14
BlackRock
New York
– -$4.8M -4,035,344 Closed
QF
15
QVT Financial
New York
– -$4.2M -3,525,000 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$2.63M -2,209,700 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$1.65M -1,382,968 Closed
Millennium Management
18
Millennium Management
New York
– -$1.16M -976,384 Closed
State Street
19
State Street
Massachusetts
– -$851K -715,398 Closed
PA
20
Pinnacle Associates
New York
– -$738K -620,203 Closed
Wellington Management Group
21
Wellington Management Group
Massachusetts
– -$667K -560,565 Closed
ABG
22
Ally Bridge Group
New York
– -$635K -533,501 Closed
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
– -$601K -505,343 Closed
N
24
Natixis
France
– -$600K -500,000 Closed
Morgan Stanley
25
Morgan Stanley
New York
– -$576K -483,593 Closed
1
2 3 4

CLVS Hedge Fund Activity: Q4 2022 in Review

15 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2022, worth a combined $525K — down 99% from $42.9M a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of CLVS and 2 opened new positions — a net loss of 88 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was S&T Bank, adding an estimated $13.2K. The largest seller was Vanguard Group, exiting entirely with an estimated $12.1M sold.

  • 15 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2022, down from 103 in Q3 2022.
  • Funds reported $525K of Clovis Oncology, Inc. stock for Q4 2022, down 99% quarter-over-quarter.
  • 2 funds opened new Clovis Oncology, Inc. positions in Q4 2022 and 90 closed out, a net change of -88 holders.
  • The largest Clovis Oncology, Inc. buyer in Q4 2022 was S&T Bank, an estimated $13.2K added.
  • The largest Clovis Oncology, Inc. seller in Q4 2022 was Vanguard Group, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2022.